Nanotechnology-based strategies for the diagnosis and treatment of intracranial neoplasms

Peleg M Horowitz; E Antonio Chiocca

doi:10.1016/j.wneu.2013.02.039

Nanotechnology-based strategies for the diagnosis and treatment of intracranial neoplasms

World Neurosurg. 2013 Jul-Aug;80(1-2):53-5. doi: 10.1016/j.wneu.2013.02.039. Epub 2013 Feb 14.

Authors

Peleg M Horowitz¹, E Antonio Chiocca

Affiliation

¹ Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA; Institute for the Neurosciences at the Brigham and Women's/Faulkner Hospital, Boston, Massachusetts, USA; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Broad Institute of MIT and Harvard, Boston, Massachusetts, USA.

PMID: 23416779
DOI: 10.1016/j.wneu.2013.02.039

No abstract available

Keywords: BBB; Blood−brain barrier; CD20; CNS; Cell targeting; Central nervous system; MRI; Magnetic resonance imaging; Nanomedicine; PCNSL; Theranostic.

Publication types

Comment

MeSH terms

Antibodies / therapeutic use*
Antigens, CD20 / immunology*
Central Nervous System Neoplasms / drug therapy*
Ferric Compounds / administration & dosage*
Humans
Lymphoma, B-Cell / therapy*
Recombinant Fusion Proteins / therapeutic use*
Streptavidin / therapeutic use*

Substances

Antibodies
Antigens, CD20
Ferric Compounds
Recombinant Fusion Proteins
ferric oxide
Streptavidin